The number of major thromboses at or prior to diagnosis was significantly higher in JAK2 patients (n = 149, 23%) compared to CALR (n = 16, 9%; p < 0.001) and TN (n = 11, 10%; p = 0.003). The gene discussed is CALR; the disease is thrombotic disease.